SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC — Lebanon, Tennessee

SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC is a clinical research site located in Lebanon, Tennessee, United States 37090.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Sponsors: Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC?

SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC conducted?

SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC has 1 clinical trials on record, with 1 currently active. Their work covers HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Is SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC accredited by Crixeo Health?

SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI TO Nashville- Lebanon Tennessee Oncology, PLLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.